Streetbeat News

Stock Prices

IONS

Ionis Pharmaceuticals, Inc. announced positive results from a Phase 2 study of ION224, a treatment for metabolic dysfunction-associated steatohepatitis (MASH), meeting primary and important secondary endpoints.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:03 am

MXCT

MaxCyte shares surged following the announcement of their Q4 financial results, which exceeded expectations. Additionally, the company provided positive guidance for FY24.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:03 am

SKIN

Beauty Health shares surged following the announcement of their Q4 revenue results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:02 am

ADCT

ADC Therapeutics (NYSE:ADCT) reported a Q4 adjusted EPS of $(0.97), missing the consensus estimate of $(0.50) by 94%. Year-over-year, this represents a 1112.5% decrease in EPS. However, Q4 sales of $16.79M exceeded expectations by 9.52%, despite being 75.94% lower than the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:02 am

ZIM

ZIM Integrated Shipping reported Q4 losses of $(1.23) per share, beating the $(1.29) estimate but marking a 135.76% decrease from last year's earnings. Sales were $1.21B, missing the $1.28B estimate and showing a 44.95% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:02 am

ADM

ADM has entered into a $1 billion accelerated share repurchase agreement, signaling a strong financial position and a commitment to returning value to shareholders. This move is likely to positively impact ADM's stock price in the short term as it reflects confidence in the company's future performance and profitability.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:02 am

DLTR

LEN

QQQ

S

SPY

TSLA

WSM

US stock futures indicate a flat open after a relief rally, with caution prevailing on Wall Street. Bitcoin surpasses $73K, while gold declines. Analysts stress the need for robust earnings to justify market strength, highlighting high S&P 500 valuations in a higher interest rate environment. SPDR S&P 500 ETF Trust (SPY) and Invesco QQQ ETF (QQQ) show slight premarket movements. Tesla, Dollar Tree, Williams-Sonoma, SentinelOne, and Lennar are in focus due to stock performance and upcoming earnings.

Portfolio Pulse from Shanthi Rexaline

March 13, 2024 | 10:49 am

DLTR

Dollar Tree projects Q1 net sales to be between $7.6B and $7.9B, compared to the estimated $7.68B. The company also forecasts Q1 earnings per share (EPS) to be in the range of $1.33 to $1.48, which is below the estimated $1.69.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 10:37 am

DLTR

Dollar Tree projects its FY24 net sales to be between $31 billion and $32 billion, surpassing the estimated $30.66 billion. Additionally, the company forecasts its FY24 EPS to range from $6.70 to $7.30, exceeding the estimated $5.96.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 10:35 am

DLTR

Dollar Tree Enterprise reported a 3.0% increase in same-store net sales, indicating a positive performance in its retail operations.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 10:33 am